site stats

Sutro biopharma stock

WebSutro Biopharma, Inc. (STRO) NasdaqGM - NasdaqGM Real Time Price. Currency in USD. 4.7700 +0.1700 (+3.70%) At close: 04:00PM EDT. 5.0000 +0.23 (+4.82%) Web10 feb 2024 · You can click the graphic below for the historical numbers, but it shows that Sutro Biopharma had US$19.3m of debt in September 2024, down from US$25.0m, one year before. But it also has US$324.2m in cash to offset that, meaning it has US$305.0m net cash. NasdaqGM:STRO Debt to Equity History February 10th 2024.

Sutro Biopharma (STRO) Stock Forecast & Price Prediction 2025, …

Web21 mar 2024 · Sutro Biopharma Quant Rating and Wall St. Analysts rating both stands with Buy (5 Very Bullish, 3 Bullish). Since the start of 2024, Sutro Biopharma shares were … WebSutro Biopharma. 111 Oyster Point Blvd South San Francisco, CA 94080 Phone: 650-881-6500 Fax: 650-553-9659. Google Map conservation of energy related people https://byfordandveronique.com

Sutro Biopharma (STRO) Stock Forecast & Price Target - TipRanks

Web13 mar 2024 · Sutro Biopharma, Inc. is a clinical stage drug discovery, development, and manufacturing company. It is focused on deploying its integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF, to create a variety of protein therapeutics, initially for cancer. It is engaged in designing therapeutics using potent ... Web6 apr 2024 · According to analysts, Sutro Biopharma's stock has a predicted upside of 200.22% based on their 12-month price targets. What analysts cover Sutro Biopharma? … conservation of energy on incline

Coherus BioSciences (NASDAQ:CHRS) versus Sutro Biopharma …

Category:STRO Interactive Stock Chart Sutro Biopharma, Inc. Stock - Yahoo …

Tags:Sutro biopharma stock

Sutro biopharma stock

Sutro Biopharma Inc. (STRO): Investors are paying attention to this stock

Web5 apr 2024 · By Sarah Baker. April 5, 2024. For the readers interested in the stock health of Sutro Biopharma Inc. (STRO). It is currently valued at $4.31. When the transactions were called off in the previous session, Stock hit the highs of $4.805, after setting-off with the price of $4.71. Company’s stock value dipped to $4.245 during the trading on the ... Web10 apr 2024 · Comparatively, Sutro Biopharma has a beta of 0.89, suggesting that its stock price is 11% less volatile than the S&P 500. Insider & Institutional Ownership 99.5% of Coherus BioSciences shares are ...

Sutro biopharma stock

Did you know?

WebSTRO Stock 12 Months Forecast. $18.67. (306.75% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Sutro Biopharma in the last 3 months. The average price target is $18.67 with a high forecast of $26.00 and a low forecast of $8.00. The average price target represents a 306.75% change from the last price of $4.59. Web27 dic 2024 · Bill Newell, Chief Executive Officer of Sutro added, "This agreement further validates our emerging clinical data surrounding the development of STRO-002.Tasly is an excellent partner for our Greater China collaboration, with a history of successful execution for developing and commercializing therapeutics. We are delighted to broaden the …

Web12 apr 2024 · Sutro Biopharma has a beta of 0.89, meaning that its stock price is 11% less volatile than the S&P 500. Comparatively, Compass Therapeutics has a beta of 0.77, … Web30 mar 2024 · The non-operating, unrealized gain of $12.1 million for the year 2024 was due to the increase since December 31, 2024 in the estimated fair value of Sutro’s holdings of Vaxcyte common stock. Vaxcyte common stock held by Sutro will be remeasured at fair value based on the closing price of Vaxcyte’s common stock on the last trading day of ...

Web27 mar 2024 · Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical … WebFind real-time STRO - Sutro Biopharma Inc stock quotes, company profile, news and forecasts from CNN Business. STRO - Sutro Biopharma Inc Stock quote - …

WebSutro Biopharma is a clinical stage company pioneering a compelling and unique way of discovering, developing and manufacturing therapeutics. Our focus is aimed primarily on …

Web11 mar 2024 · Business. Sutro Biopharma Inc. (NASDAQ:STRO) concluded the trading at $5.13 on Friday, March 10 with a fall of -2.47% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $5.26 and 5Y monthly beta was reading 0.88 with its price kept floating in the range of $5.01 and $5.25 on the day. conservation of energy meanWeb21 mar 2024 · Wells Fargo analyst Derek Archila downgraded Sutro Biopharma (NASDAQ:STRO) to Equal Weight from Overweight with a price target of $8, down from $15, after taking over coverage of the name.The firm ... conservation office lcsdWeb3 apr 2024 · JMP Securities analyst Reni Benjamin reiterated a Buy rating on Sutro Biopharma (STRO – Research Report) today and set a price target of $17.00.The company’s shares closed last Friday at $4.62 editing packs on tenorWebThe Sutro Biopharma stock prediction for 2025 is currently $ 4.66, assuming that Sutro Biopharma shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a -2.37% increase in the STRO stock price. Sutro Biopharma Stock Prediction 2030. conservation of energy thermodynamicsWeb10 apr 2024 · Sutro Biopharma (NASDAQ:STRO) has a market capitalization of $259.89 million and generates $67.77 million in revenue each year. The company earns $ … editing pacman confWebSutro Biopharma, Inc. (STRO) Stock Price, News, Quote & History - Yahoo Finance Sutro Biopharma, Inc. (STRO) NasdaqGM - NasdaqGM Real Time Price. Currency in USD … editing pack leaked discordWebThe Sutro Biopharma stock prediction for 2025 is currently $ 4.66, assuming that Sutro Biopharma shares will continue growing at the average yearly rate as they did in the last … editing pack files on mac